RBTT-05. A SINGLE-ARM, OPEN-LABEL, PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF ABEMACICLIB IN PATIENTS WITH RECURRENT OLIGODENDROGLIOMA: TRIALS IN PROGRESS

BACKGROUND: Oligodendroglioma is a rare primary brain tumor characterized by mutation in the IDH1/IDH2 genes and codeletion of chromosomes 1p and 19q. Although median overall survival extends beyond 10 years for patients with oligodendroglioma who receive adjuvant radiation and alkylating chemothera...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: Bagley, Stephen, Nasrallah, MacLean, O’Rourke, Donald, Hussain, Jasmin, Maloney-Wilensky, Eileen, Prior, Timothy, Brem, Steven, Desai, Arati
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2019
Pynciau:
Randomized Brain Tumor Trials in Development
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847756/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.917
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg